V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240002261 | 240006994 | 1.52 | null | null | 2019-12-15 | 2019-12-15 | ALL UKALL2011 Maintenance C1 | 02 | Y | FCR | 100357336 |
| 240002263 | 240006996 | 1.83 | 74.8 | null | 2020-11-21 | 2020-11-23 | Cytarabine High Dose | 02 | null | CYCLOPHOSPHAMIDE + CYTARABINE + DOXORUBICIN + ETOPOSIDE + IFOSFAMIDE + METHOTREXATE + RITUXIMAB + VINCRISTINE | 101137393 |
| 240002264 | 240006997 | 1.69 | 96.1 | null | 2020-08-03 | 2020-09-01 | CLADRIBINE | 02 | null | BUSULFAN | 100508934 |
| 240002271 | 240006999 | 1.54 | 90.2 | null | null | 2019-07-22 | ALL UKALL2011 Del Int A Pt1 (PAsp) | null | null | METHOTREXATE + VINBLASTINE | 100219805 |
| 240002275 | 240007001 | 1.69 | 85.5 | Curative (C) | 2016-11-30 | 2016-12-07 | Cytarabine High Dose | 02 | N | CARMUSTINE + CYTARABINE + ETOPOSIDE + MELPHALAN | 100438684 |
| 240002276 | 240007002 | 1.72 | 65.1 | null | 2017-07-25 | 2017-08-02 | R Chlorambucil | 02 | null | ALL ALLR3: S/IR CONS | 100882542 |
| 240002277 | 240007003 | 1.5 | 105 | null | 2019-02-13 | 2019-02-17 | null | 02 | null | AML MYECHILD 01 IT CYT | 100495092 |
| 240002279 | 240007004 | 1.67 | 81.4 | null | null | 2012-11-02 | DA-EPOCH-R | null | null | AML INTERIM GUIDELINES FLAG-IDA | 101552226 |
| 240002280 | 240007005 | 0 | 12.5 | Palliative (P) | 2018-05-02 | 2018-05-07 | DA-EPOCH-R | 02 | N | ENRICH TRIAL | 101225765 |
| 240002282 | 240007007 | 1.85 | 83.6 | null | 2019-08-24 | 2019-08-24 | Trial Unspecified | 02 | null | VENETOCLAX | 101256721 |
| 240002287 | 240007011 | 0 | 55.3 | null | 2016-03-14 | 2016-11-05 | null | 02 | null | CHLORAMBUCIL + OBINUTUZUMAB | 101567333 |
| 240002293 | 240007013 | 1.62 | 28.5 | null | 2017-10-22 | 2017-11-04 | CHLVPP | null | null | CHLORAMBUCIL + PROCARBAZINE + VINBLASTINE | 100321696 |
| 240002294 | 240007014 | null | 49.6 | null | null | 2017-10-12 | Carboplatin + Pemetrexed | null | null | ADE | 100792389 |
| 240002298 | 240007015 | 1.67 | 90.3 | Curative (C) | null | 2021-07-23 | FLAG + Idarubicin | null | null | AML MYECHILD 01 A MITOZANTRONE/CYTARABINE | 100054492 |
| 240002300 | 240007016 | 1.89 | 102 | null | 2020-01-05 | 2020-01-05 | Bortezomib + Daratumumab | 02 | null | PACLITAXEL | 101052048 |
| 240002301 | 240007017 | 1.53 | 93 | Curative (C) | 2019-03-26 | 2019-03-31 | Brentuximab | 02 | null | CVP R | 100615797 |
| 240002306 | 240007018 | 1.76 | 16.2 | null | 2019-06-24 | 2019-06-27 | null | 02 | null | PEG INTERFERON | 101002930 |
| 240002307 | 240007019 | 1.73 | 70.9 | Curative (C) | 2020-08-29 | 2020-09-05 | null | 02 | null | CLADRIBINE | 101536675 |
| 240002309 | 240007020 | 1.63 | 67.6 | Palliative (P) | null | 2020-09-28 | Alemtuz+Fludara+Melphalan RIC MUD | null | N | CYTARABINE + METHOTREXATE + RITUXIMAB + THIOTEPA | 101022921 |
| 240002311 | 240007022 | 0 | 27.4 | null | 2019-01-24 | 2019-03-01 | Cyclophosphamide+Fludara+TBI Allo | 02 | null | ALL UKALL2011 AUG BFM CONS C | 101215538 |
| 240002316 | 240007026 | 0 | 26.8 | Curative (C) | null | 2018-11-30 | NIVOLUMAB | null | null | CYTARABINE HIGH DOSE | 100992913 |
| 240002318 | 240007028 | 1.71 | 28.05 | Curative (C) | 2020-05-06 | 2020-05-06 | ENRICH Trial | 02 | N | BUSULFAN | 100966846 |
| 240002323 | 240007030 | 1.66 | 86.8 | Adjuvant (A) | null | 2020-07-09 | CARBO + ETOPOSIDE + VINCRISTINE | Y | N | FLAIR TRIAL | 101286007 |
| 240002326 | 240007033 | 1.79 | 74.6 | Palliative (P) | 2017-07-10 | 2017-07-10 | Cyclophosphamide High Dose | 02 | N | CARBOPLATIN + VINCRISTINE | 101104111 |
| 240002328 | 240007034 | 1.69 | null | null | null | 2019-04-29 | BENDAMUSTINE + POLATUZUMAB VEDOTIN + RITUXIMAB | null | null | IBRUTINIB | 101252668 |
| 240002331 | 240007035 | 1.68 | 77.1 | null | 2017-06-28 | 2017-06-28 | CVP R | 02 | null | AML INTERIM GUIDELINES FLAG-IDA | 101376472 |
| 240002335 | 240007037 | 1.54 | 119.2 | Curative (C) | 2020-01-19 | 2020-02-07 | Triple Intrathecal | N | null | CYTARABINE + FLUDARABINE + IDARUBICIN | 100603756 |
| 240002342 | 240007039 | 1.63 | 80 | Curative (C) | 2017-10-01 | 2017-10-04 | Venetoclax | 02 | null | CYTARABINE HIGH DOSE | 101618208 |
| 240002343 | 240007040 | 1.65 | 68 | null | null | 2022-05-15 | GEM-P | null | null | CYTARABINE + DAUNORUBICIN | 101426908 |
| 240002344 | 240007041 | 1.75 | 45.1 | null | null | 2020-05-27 | null | null | null | LENALIDOMIDE | 101583614 |
| 240002345 | 240007042 | 1.7 | 53.3 | null | 2020-11-25 | 2020-11-25 | AML MyeChild 01 HD AraC | 02 | null | AML MYECHILD 01 IT CYT | 100710683 |
| 240002348 | 240007043 | 1.43 | 71 | Curative (C) | null | 2017-08-17 | Cytarabine High Dose | null | N | CYTARABINE + DAUNORUBICIN | 101476143 |
| 240002349 | 240007044 | 1.64 | 88 | null | null | 2021-11-12 | null | null | null | CISPLATIN + GEMCITABINE + RITUXIMAB | 101659815 |
| 240002352 | 240007047 | 1.86 | 85.15 | Curative (C) | 2018-11-30 | 2018-12-16 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | null | ANTI-THYMOCYTE GLOBULIN + BUSULFAN + FLUDARABINE | 101831215 |
| 240002355 | 240007049 | 1.82 | 84.8 | Curative (C) | null | 2019-07-02 | FLAIR trial | null | N | RUXOLITINIB | 100796451 |
| 240002360 | 240007051 | 1.62 | 71 | Curative (C) | null | 2020-01-25 | null | null | null | BENDAMUSTINE + POLATUZUMAB VEDOTIN + RITUXIMAB | 101498904 |
| 240002361 | 240007052 | 1.83 | 52.8 | Palliative (P) | null | 2018-06-21 | ALL UKALL2011 Ind A Std Dex (PAsp) | null | N | NOT MATCHED | 100265284 |
| 240002363 | 240007054 | 1.83 | 70.6 | null | 2017-07-07 | 2017-07-24 | ALL UKALL2011 IndB Std Dex (PegAsp) | 02 | null | CYTARABINE + MITOXANTRONE | 101792096 |
| 240002367 | 240007056 | 1 | 72.2 | null | null | 2016-07-02 | Triple / Double Intrathecal Therapy + hydrocortisone | null | null | DA | 101074915 |
| 240002371 | 240007058 | 1.79 | 69 | null | 2016-03-11 | 2016-06-13 | AML Relapsed FLA | 02 | null | VENETOCLAX | 100978389 |
| 240002374 | 240007060 | 1.65 | 93 | null | null | 2019-04-28 | Venetoclax | null | null | CHLORAMBUCIL + RITUXIMAB | 100187681 |
| 240002377 | 240007063 | 1.68 | 62.8 | Curative (C) | 2019-04-30 | 2019-08-06 | null | 02 | N | AML16 TRIAL | 101605120 |
| 240002385 | 240007066 | 1.75 | 63.8 | null | 2019-02-23 | 2019-03-07 | null | 02 | null | CISPLATIN + GEMCITABINE | 101826085 |
| 240002390 | 240007070 | 1.46 | 29.6 | null | null | 2018-02-21 | null | null | null | AML MYECHILD 01 FLA | 100782903 |
| 240002392 | 240007072 | 1.67 | 81 | Palliative (P) | 2018-12-21 | 2018-12-24 | null | 02 | N | METHOTREXATE + PEGASPARAGINASE | 100607425 |
| 240002397 | 240007075 | 1.75 | 80.8 | null | 2016-05-26 | 2016-06-19 | ATG + Busulfan + Fludarabine | N | null | AML MYECHILD 01 HD ARAC | 100514256 |
| 240002399 | 240007076 | 1.84 | 73.2 | null | null | 2018-02-08 | CVP R | null | null | PEG INTERFERON | 101433239 |
| 240002403 | 240007079 | 0 | 74.6 | null | 2019-02-11 | 2019-02-23 | Brentuximab | N | null | NOT MATCHED | 100824587 |
| 240002406 | 240007080 | 0 | 108 | null | null | 2020-07-06 | Acalabrutinib | null | null | RUXOLITINIB | 101715564 |
| 240002412 | 240007082 | null | 50.5 | null | 2019-08-03 | 2019-10-15 | Etoposide oral | N | null | BENDAMUSTINE | 100491108 |